DWP450 Versus Botox in Treatment of Post Stroke Upper Limb Spasticity

Trial Profile

DWP450 Versus Botox in Treatment of Post Stroke Upper Limb Spasticity

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle spasticity
  • Focus Registrational; Therapeutic Use
  • Sponsors Daewoong Pharmaceutical
  • Most Recent Events

    • 01 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top